Sector: MedicalMomenta Pharmaceuticals, Inc. (NASDAQ: MNTA)
Headlines
- Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2009
Nov 05, 2009 08:33 AM | MNTA
- Momenta Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference
Oct 30, 2009 08:02 AM | MNTA
- Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2009 Financial Results
Oct 29, 2009 11:39 AM | MNTA
- FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 13, 2009 12:34 PM | ACCP, APOL, CLDA, CRI, CRL, CYTX
- Momenta Pharma (MNTA): Timing Uncertain, Approval Likely for M-Enoxaparin
Oct 06, 2009 05:49 PM | MNTA, MYL, NVS, SNY, TEVA
- Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): A Good Buy
Oct 02, 2009 01:00 PM | BIIB, ELN, HSP, MNTA, MYL, NVS
- Momenta Pharmaceuticals Announces Positive Results From M118 EMINENCE Trial
Sep 24, 2009 02:46 PM | MNTA
- Momenta Pharmaceuticals Prices Underwritten Offering of Common Stock
Sep 23, 2009 07:31 AM | MNTA
- Momenta Pharmaceuticals to Present At the 2009 UBS Global Life Sciences Conference
Sep 21, 2009 09:46 AM | MNTA, UBS
- Momenta Pharmaceuticals Announces EMINENCE Trial Results to be Presented At the 21st Annual Transcatheter Cardiovascular Therapeutics (TCT) Meeting
Sep 09, 2009 08:02 AM | MNTA
- Teva Comments on Mylan Paragraph IV Filing for COPAXONE®; Files Lawsuit Against Generic Filer for Patent Infringement
Oct 16, 2009 05:52 PM | MNTA, MYL, TEVA
- Momenta Pharmaceuticals, Inc. Announces Closing of Offering and Exercise of Over-Allotment Option
Sep 28, 2009 01:51 PM | MNTA
- Momenta Pharmaceuticals Reports Financial Results for the Second Quarter of 2009
Aug 06, 2009 08:32 AM | MNTA
- Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2009 Financial Results
Jul 23, 2009 04:31 PM | MNTA
- Momenta Pharmaceuticals Announces Top-Line Results From the M118 EMINENCE Trial
Jun 29, 2009 04:29 PM | MNTA
- Momenta Pharmaceuticals Announces Appointment of Bruce L. Downey to Board of Directors
Jun 12, 2009 08:01 AM | MNTA
- Momenta Pharmaceuticals to Present At the Goldman Sachs 30th Annual Global Healthcare Conference
Jun 03, 2009 03:00 PM | MNTA
- Momenta Pharmaceuticals to Present At the Deutsche Bank 34th Annual Health Care Conference
May 15, 2009 04:30 PM | MNTA
- Momenta Pharmaceuticals to Present At the Deutsche Bank 34th Annual Health Care Conference
May 12, 2009 02:50 PM | MNTA
- Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2009
May 07, 2009 08:30 AM | MNTA
- Form 4 Bishop John E For: Sep 14 (10K)
Sep 16, 2009 06:35 PM
- Form 4 Shea Richard P For: Aug 24 (10K)
Aug 26, 2009 04:02 PM
- Form 4 Bishop John E For: Aug 24 (10K)
Aug 26, 2009 03:50 PM
- Form 4 WHEELER CRAIG A For: Aug 25 (10K)
Aug 26, 2009 03:37 PM
- Form 4 Leicher Bruce For: Aug 19 (10K)
Aug 21, 2009 05:30 PM
- Form 4 Bishop John E For: Jun 15 (10K)
Jun 16, 2009 08:16 PM
- Form 4 DOWNEY BRUCE For: Jun 11 (10K)
Jun 11, 2009 06:29 PM
- Form 3 DOWNEY BRUCE For: Jun 11 (10K)
Jun 11, 2009 06:25 PM
- Form 4 CLARKE JOHN K For: Jun 11 (10K)
Jun 11, 2009 05:15 PM
- Form 4 SULAT JAMES R For: Jun 11 (10K)
Jun 11, 2009 05:15 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MNTA
|
Compare to S&P
|
| YTD |
-21.38 %
|
-31.47 %
|
| 4 Weeks |
-7.32 %
|
-8.30 %
|
| 12 Weeks |
-9.43 %
|
-11.68 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 6.52 %
|
|
EPS Growth in Last Year: -2.38 %
|
|
Sales Growth in Last Quarter: 65.54 %
|
|
Sales Growth in Last Quarter: 85.38 %
|
|
